Foresite Capital Fund VI LP - 30 Jun 2025 SCHEDULE 13G/A Report for CASI Pharmaceuticals, Inc. Ordinary Shares, par value $0.0001 (CASI)

Filing Manager
Foresite Capital Fund VI LP
Reporting Manager
Foresite Capital Fund VI, L.P.
Security
CASI Pharmaceuticals, Inc. Ordinary Shares, par value $0.0001
Symbol
CASI
Shares outstanding
15,433,745 shares
Disclosed Ownership
787,121 shares
Ownership
5.1%
Form type
SCHEDULE 13G/A
Filing time
12 Aug 2025, 16:05:16 UTC
Date of event
30 Jun 2025
Next filing
14 Nov 2025
SEC
View on sec.gov

Reporting Managers (3)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Foresite Capital Fund VI, L.P. 5.1% 787,121 787,121 0 /s/ James Tananbaum James Tananbaum, Managing Member of the General Partner
Foresite Capital Management VI, LLC 5.1% 787,121 787,121 0 /s/ James Tananbaum James Tananbaum, Managing Member
James Tananbaum 5.1% 787,121 787,121 0 /s/ James Tananbaum James Tananbaum